294 results on '"Caldarola, Giacomo"'
Search Results
2. Italian National Registry of Alopecia Areata: an epidemiological study of 699 Italian patients
3. Clinical, epidemiological, and therapeutic hallmarks of pyoderma gangrenosum: a case series of 35 patients.
4. Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study.
5. Evaluation of the Impact of Night Shift Work on Disease Severity in Psoriatic Patients: A Case-Control Study with Clinical, Hormonal, and Immunological Evaluation.
6. Impact of Body Mass Index on the Efficacy of Biological Therapies in Patients with Psoriasis: A Real-World Study
7. Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER – study)
8. Drug survival of biologics and non‐biologics in patients affected by palmoplantar psoriasis: a “real‐world”, mono‐center experience
9. Awareness of obesity among patients with psoriasis
10. Infectious adverse events in patients with atopic dermatitis treated with baricitinib
11. Ixekizumab Effectiveness and Safety in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Multicenter, Retrospective Observational Study
12. Paradoxical skin reaction to certolizumab, an overlap of neutrophilic dermatoses.
13. Paradoxe Hautreaktion auf Certolizumab mit Überlappung neutrophiler Dermatosen: Paradoxical skin reaction to certolizumab, an overlap of neutrophilic dermatoses.
14. Low grade of satisfaction related to the use of current systemic therapies among pustular psoriasis patients: a therapeutic unmet need to be fulfilled.
15. Drug survival of biologics and non‐biologics in patients affected by palmoplantar psoriasis: a "real‐world", mono‐center experience.
16. 2-Year Experience with Risankizumab in the Treatment of Plaque Psoriasis in Lazio Region, Italy
17. The preclinical discovery and development of deucravacitinib for the treatment of psoriasis
18. Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis)
19. Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study
20. Childhood trauma and resilience in psoriatic patients: A preliminary report
21. Awareness of obesity among patients with psoriasis.
22. Risankizumab: Daily Practice Experience of High Need Patients
23. A multidisciplinary approach for patients with moderate-to-severe psoriasis: an advisable network of management
24. Effectiveness of risankizumab in the treatment of palmoplantar psoriasis: a 52-week Italian real-life experience
25. A case of eczematous eruption occurring during treatment with risankizumab
26. Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study
27. Drug survival of methotrexate and predictor factors for discontinuation in psoriasis.
28. Risankizumab for the treatment of moderate‐to‐severe psoriasis: A multicenter, retrospective, 1 year real‐life study
29. Tildrakizumab in moderate‐to‐severe plaque psoriasis: A multicenter, retrospective, real‐life study
30. Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis
31. Lichen sclerosus of the glans simulating melanoma
32. Biological agents targeting interleukin-13 for atopic dermatitis
33. Severe and resistant palmar psoriasis successfully treated with risankizumab
34. Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry
35. Real-life experience with ixekizumab in plaque psoriasis: a multi-center, retrospective, 3-year study
36. Ixekizumab exposure associated with myelitis: A case report and a literature review
37. Therapeutic Impact and Management of Persistent Head and Neck Atopic Dermatitis in Dupilumab-Treated Patients
38. Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum
39. Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy
40. Human leukocyte antigen-B*58:01 allele in a familial case of Stevens–Johnson syndrome induced by allopurinol
41. Therapeutic Impact and Management of Persistent Head and Neck Atopic Dermatitis in Dupilumab-Treated Patients.
42. Free and total vitamin D in psoriatic patients treated with biological drugs
43. Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a ‘patchy cutaneous’ immune suppression?
44. Comparison of short- and long-term effectiveness of ixekizumab and secukinumab in real-world practice
45. Successful Combination of Systemic Agents for the Treatment of Atopic Dermatitis Resistant to Dupilumab Therapy
46. Erfolgreiche Behandlung des therapierefraktären Sweet‐Syndroms mit Adalimumab
47. A case of chronic disseminated lupus erythematosus in a psoriatic patient receiving ustekinumab
48. New JAK inhibitors for the treatment of psoriasis and psoriatic arthritis
49. Multiple eruptive plaque-like dermatofibromas during anti-TNFα treatment
50. The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.